lazertinib

Italy

Drugs containing this active substance

  • LAZCLUZE

    Lazcluze is an anticancer drug used to treat adults with an advanced stage of a type of non-small cell lung cancer that presents specific variations (exon 19 deletion or exon 21 substitution mutation) in the EGFR gene. It is used in combination with amivantamab.

    Form: tablets, film-coated

    Active substance Dosage
    lazertinib -

    ATC: L01EB09

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.